Potassium Acetate → HCID 19000639, compound
Reaction equation
Br[CH2:2][C:3]1[CH:16]=[C:15]2[C:6]([C:7](=[O:18])[C:8]3[C:13]([C:14]2=[O:17])=[CH:12][CH:11]=[CH:10][CH:9]=3)=[C:5]2[CH2:19][CH2:20][CH2:21][C:4]=12.[C:22]([O-:25])(=[O:24])[CH3:23].[K+]>CN(C)C=O.ClCCl>[C:22]([O:25][CH2:2][C:3]1[CH:16]=[C:15]2[C:6]([C:7](=[O:18])[C:8]3[C:13]([C:14]2=[O:17])=[CH:12][CH:11]=[CH:10][CH:9]=3)=[C:5]2[CH2:19][CH2:20][CH2:21][C:4]=12)(=[O:24])[CH3:23]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 2,3-dihydro-4-bromomethyl-1H-cyclopent[a]-anthracene-6,11-dione (173 mg, 0.51 mmol) in dimethylformamide (10 ml) is added anhydrous potassium acetate (200 mg) at 0° C. and stirred for 2.5 hours. The mixture is diluted with dichloromethane (50mL), washed with H2O, dried (Na2SO4), and evaporated in vacuo to dryness. The residue is chromatographed on a silica gel column (2×30 cm) using toluene/ethyl acetate (9:1 v/v) as the eluent. The main fraction is collected, evaporated, and the solid residue is recrystallized from EtOH to afford 4-acetoxymethyl-2,3-dihydro-1H-cyclopent[a]anthracene-6,11dione, 81 mg (50%), mp 160°-161° C. 1H NMR (CDCl3): δ2.18 (3H, s, Ac), 2.24 (2H, t, J=7.6 Hz, CH2 -2), 2.98 (2H, q, J=7.6 Hz, CH2 -3), 3.53 (2H, t, J=7.6 Hz, CH2 -1), 5.20 (2H, S, CH2 --OAc), 7.76-8.30 (5H, m, Ar--H). The product is used directly in the next step without further purification.
Workup
- washwashed with H2O
- dry with materialdried (Na2SO4)
- customevaporated in vacuo to dryness
- customThe residue is chromatographed on a silica gel column (2×30 cm)
- customThe main fraction is collected
- customevaporated
- customthe solid residue is recrystallized from EtOH
Sources & evidence
- ORD record
- ord-0b0a98a753994c4ca84061b7208deca4
- Source dataset
- uspto-grants-1995_12
- Patent number
- US05476952
Reaction notes
Loading…